A Phase 3, randomized, double-blind trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine given as a series of 2 infant doses and 1 toddler dose in healthy infants (NeXXstep)

Investigators: Andrea Meehan, Beth Arrowsmith, Camille Gibson, Christina Anthony, Fiona McDonald, Heidi Hutton, Jan Jones, Jane Jones, Jennifer Kent, Joanne Ong, Kieran Veale, Lisa Montgomery, Miriam West, Nikki Schultz, Peter Richmond, Ushma Wadia

Project description

This study involving about 1200 children will evaluate the coverage and protection of an investigational pneumococcal vaccine compared to an approved pneumococcal vaccine. We also want to find out about the safety of the investigational vaccine when it is given with other routine childhood vaccinations.